Market Overview:
The global inflammatory bowel disease therapy market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of inflammatory bowel diseases, rising awareness about these diseases, and technological advancements in the field of inflammatory bowel disease therapy. The global inflammatory bowel disease therapy market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into ulcerative colitis, Crohn’s disease, and others. On the basis of application, the market is segmented into hospitals, medical research organizations (MROs), and others. The hospital segment dominates this market owing to increased incidence rates for IBD patients in hospitals as compared to other settings such as clinics or private practices.
Product Definition:
Inflammatory bowel disease therapy is the medical treatment of inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis. It includes medications, surgery, and other therapies. The importance of IBD therapy is that it helps to control the symptoms of these diseases and may help to prevent complications.
Ulcerative Colitis:
Ulcerative colitis is a type of Inflammatory Bowel Disease (IBD) that causes sores or ulcers in the innermost part of the colon and rectum. People with ulcerative colitis may also experience diarrhea, abdominal pain, loss of appetite, nausea and/or vomiting. The exact cause of ulcerative colitis is unknown; however, it may be triggered by infection or injury to the GI tract.
Crohns Disease:
Crohn's disease is a chronic, incurable, and often fatal illness. It has been estimated that 1 in 100 people suffer from this condition. The cause of Crohn's disease is unknown but the risk may be genetic. There are approximately 50 to 100 different types of Crohn’s diseases (CD) based on the location of the affected part of intestine involved and about 10 to 15 different types based on symptoms.
Application Insights:
The other application segment held the largest share of over 70.0% in 2017. The growing prevalence of chronic conditions, such as heart diseases, cancer and diabetes along with the rising geriatric population is expected to drive demand for inflammatory bowel disease therapies during the forecast period.
In addition, a rise in consumer spending on healthcare due to increasing awareness about preventive care coupled with rising concerns regarding Inflammatory Bowel Disease (IBD) is anticipated to fuel demand for these drugs during the forecast period. Increasing R&D activities pertaining to new drug development and introduction of novel products are further expected to boost market growth over the coming years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to a rise in prevalence of IBD, increasing awareness about treatment options, and availability of effective therapies. Moreover, presence of key players is also expected to contribute toward growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising healthcare expenditure by governments and private organizations as well as increasing incidence rates of IBD in this region. In addition, growing medical tourism industry due to availability of effective treatments at affordable costs will further propel regional growth during the forecast period.
Growth Factors:
- Increasing incidence of inflammatory bowel disease (IBD)
- Growing awareness about IBD and its treatment options
- Rising demand for better and more effective therapies for IBD
- Technological advancements in the field of inflammatory bowel disease therapy 5. Growing number of clinical studies on new therapeutic approaches for IBD
Scope Of The Report
Report Attributes
Report Details
Report Title
Inflammatory Bowel Disease Therapy Market Research Report
By Type
Ulcerative Colitis, Crohns Disease, Others
By Application
Hospital, Medical Research Organization, Other
By Companies
Johnson & Johnson, AbbVie, Takeda Pharmaceutical Company, Abbott, Celgene Corporation, Innovate Biopharma, Cosmo Pharmaceuticals, Gilead Sciences, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
202
Number of Tables & Figures
142
Customization Available
Yes, the report can be customized as per your need.
Global Inflammatory Bowel Disease Therapy Market Report Segments:
The global Inflammatory Bowel Disease Therapy market is segmented on the basis of:
Types
Ulcerative Colitis, Crohns Disease, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Medical Research Organization, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- AbbVie
- Takeda Pharmaceutical Company
- Abbott
- Celgene Corporation
- Innovate Biopharma
- Cosmo Pharmaceuticals
- Gilead Sciences
- Pfizer
Highlights of The Inflammatory Bowel Disease Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ulcerative Colitis
- Crohns Disease
- Others
- By Application:
- Hospital
- Medical Research Organization
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Inflammatory Bowel Disease Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Inflammatory bowel disease therapy is a treatment plan that aims to reduce inflammation in the digestive system. This can be done through medications, lifestyle changes, or a combination of both.
Some of the key players operating in the inflammatory bowel disease therapy market are Johnson & Johnson, AbbVie, Takeda Pharmaceutical Company, Abbott, Celgene Corporation, Innovate Biopharma, Cosmo Pharmaceuticals, Gilead Sciences, Pfizer.
The inflammatory bowel disease therapy market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Inflammatory Bowel Disease Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Inflammatory Bowel Disease Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Inflammatory Bowel Disease Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Inflammatory Bowel Disease Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Inflammatory Bowel Disease Therapy Market Size & Forecast, 2018-2028
4.5.1 Inflammatory Bowel Disease Therapy Market Size and Y-o-Y Growth
4.5.2 Inflammatory Bowel Disease Therapy Market Absolute $ Opportunity
Chapter 5 Global Inflammatory Bowel Disease Therapy Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Inflammatory Bowel Disease Therapy Market Size Forecast by Type
5.2.1 Ulcerative Colitis
5.2.2 Crohns Disease
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Inflammatory Bowel Disease Therapy Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Inflammatory Bowel Disease Therapy Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Medical Research Organization
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Inflammatory Bowel Disease Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Inflammatory Bowel Disease Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Inflammatory Bowel Disease Therapy Analysis and Forecast
9.1 Introduction
9.2 North America Inflammatory Bowel Disease Therapy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Inflammatory Bowel Disease Therapy Market Size Forecast by Type
9.6.1 Ulcerative Colitis
9.6.2 Crohns Disease
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Inflammatory Bowel Disease Therapy Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Medical Research Organization
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Inflammatory Bowel Disease Therapy Analysis and Forecast
10.1 Introduction
10.2 Europe Inflammatory Bowel Disease Therapy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Inflammatory Bowel Disease Therapy Market Size Forecast by Type
10.6.1 Ulcerative Colitis
10.6.2 Crohns Disease
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Inflammatory Bowel Disease Therapy Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Medical Research Organization
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Inflammatory Bowel Disease Therapy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Inflammatory Bowel Disease Therapy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Inflammatory Bowel Disease Therapy Market Size Forecast by Type
11.6.1 Ulcerative Colitis
11.6.2 Crohns Disease
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Inflammatory Bowel Disease Therapy Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Medical Research Organization
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Inflammatory Bowel Disease Therapy Analysis and Forecast
12.1 Introduction
12.2 Latin America Inflammatory Bowel Disease Therapy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Inflammatory Bowel Disease Therapy Market Size Forecast by Type
12.6.1 Ulcerative Colitis
12.6.2 Crohns Disease
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Inflammatory Bowel Disease Therapy Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Medical Research Organization
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Inflammatory Bowel Disease Therapy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Inflammatory Bowel Disease Therapy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Inflammatory Bowel Disease Therapy Market Size Forecast by Type
13.6.1 Ulcerative Colitis
13.6.2 Crohns Disease
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Inflammatory Bowel Disease Therapy Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Medical Research Organization
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Inflammatory Bowel Disease Therapy Market: Competitive Dashboard
14.2 Global Inflammatory Bowel Disease Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson
14.3.2 AbbVie
14.3.3 Takeda Pharmaceutical Company
14.3.4 Abbott
14.3.5 Celgene Corporation
14.3.6 Innovate Biopharma
14.3.7 Cosmo Pharmaceuticals
14.3.8 Gilead Sciences
14.3.9 Pfizer
